SCHEMBL29988002

SCHEMBL29988002

c1ccc(-c2nnc(-c3ccc(-c4ccccc4-c4ccccc4-c4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)o2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 14/20 0.51
NPC1 O15118 13/20 0.51
SMN1; SMN2 Q16637 8/20 0.51
HPGD P15428 7/20 0.51
ALDH1A1 P00352 7/20 0.51
KDM4E B2RXH2 6/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
GAA P10253 2/20 0.47
TSHR P16473 3/20 0.45
NFKB1 P19838 3/20 0.45
NFKB2 Q00653 3/20 0.45
RELA Q04206 3/20 0.45
POLB P06746 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
MAPT P10636 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1950268 1.00 RAB9A (0.51) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL13426946 0.99 RAB9A (0.50) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL13426948 0.97 RAB9A (0.52) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL34467620 0.94 RAB9A (0.46) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL13426986 0.94 RAB9A (0.46) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL404737 0.93 NPC1 (0.57) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL29374218 0.93 NPC1 (0.57) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL13427062 0.92 RAB9A (0.45) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL13426983 0.92 RAB9A (0.45) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL13426944 0.92 RAB9A (0.45) RAB9ANPC1SMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260123275-A1 Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LAB (JP) 2026-04-30 US disclosed
US-12484439-B2 Light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-11-25 US disclosed
US-20220328784-A1 Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2022-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260123275-A1 Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SUN2, LEF1, CACNA1F RAB9A 3258/4885NPC1 2883/4885SMN1; SMN2 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.